I recall Leslie saying at one of the Non-deal roads shows, that Imugene prides itself on only hiring the very best, and knowing how respected Leslie Chong is even with some of our doubtful holders we have no reason to disbelieve her.
Reading some of the comments following this announcement, I can't help thinking that some on here cannot see the forest for the trees.
Each step along Imugene's growth/expansion there appears to be calculated and thoughtful decisions, IMO, now saying that I am not very familiar with credit raising so I will leave that for others to comment.
Everyone must make their own decisions according to their risk profile, but I am more than happy to continue to accumulate where possible in this wonderful company that continues to strive to find better solutions for the safe and efficacious treatment of this heinous disease.
DYOR opinion only
Ann: Imugene Appoints Dr John Byon as SVP Clinical Development, page-50
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.002(3.64%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.3¢ | $521.9K | 9.645M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 749749 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 452962 | 3 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |